Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
1,Nepsilon-etheno-ADP-ribose + H2O
1,Nepsilon-etheno-AMP-ribose + phosphate
-
fluorogenic substrate
the product is converted to fluorescent 1,Nepsilon-etheno-adenosine by alkaline phosphatase for detection
-
?
2',3'-cAMP + H2O
3'AMP
-
-
-
?
8-oxo-dADP + H2O
?
-
-
-
?
8-oxo-dGDP + H2O
8-oxo-dGMP + phosphate
-
-
-
?
8-oxo-dGDP + H2O
?
-
-
-
?
8-oxo-dGTP + H2O
?
the enzyme hardly acts on 8-oxo-dGTP
-
-
?
ADP-D-ribose + H2O
AMP + D-ribose 5-phosphate
ADP-glucose + H2O
AMP + alpha-D-glucose 1-phosphate
ADP-mannose + H2O
AMP + D-mannose 1-phosphate
ADP-ribose + H2O
AMP + D-ribose 5-phosphate
ADP-ribose + H2O
AMP + ribose 5-phosphate
ADPribose + H2O
AMP + D-ribose 5-phosphate
cADP-ribose + H2O
N1-(5-phosphoribosyl)-AMP + phosphate
-
-
-
?
CDP-choline + H2O
CMP + choline phosphate
-
-
-
?
CDP-choline + H2O
CMP + phosphocholine
reaction of EC 3.6.1.53
-
-
?
CDP-glucose + H2O
CMP + glucose 5-phosphate
-
at 5% of the activity with ADPribose
-
-
?
cyclic ADP-ribose + H2O
N1-(5-phosphoribosyl)-AMP
-
-
-
?
diadenosine 5',5''-diphosphate + H2O
?
20% the activity with ADP-ribose
-
-
?
GDP-glucose + H2O
GMP + glucose 5-phosphate
GDP-mannose + H2O
GMP + D-mannose 1-phosphate
IDP-ribose + H2O
IMP + D-ribose 5-phosphate
-
138% of the activity with ADPribose
-
-
?
IDP-ribose + H2O
IMP + ribose 5-phosphate
IDPribose + H2O
IMP + D-ribose 5-phosphate
77% of the activity with ADPribose
-
-
?
NAD+ + H2O
AMP + NMN
7% of the activity with ADP-ribose
-
-
?
NADP+ + H2O
nicotinic acid mononucleotide + phosphate
-
-
-
?
NADPH + H2O
AMP + ?
12% of the activity with ADP-ribose
-
-
?
UDP-galactose + H2O
UDP + galactose
7% of the activity with ADP-ribose
-
-
?
UDP-glucose + H2O
UMP + glucose 5-phosphate
UDP-mannose + H2O
UMP + D-mannose 1-phosphate
additional information
?
-
ADP-D-ribose + H2O
AMP + D-ribose 5-phosphate
-
-
-
?
ADP-D-ribose + H2O
AMP + D-ribose 5-phosphate
-
-
-
-
?
ADP-D-ribose + H2O
AMP + D-ribose 5-phosphate
-
-
-
?
ADP-D-ribose + H2O
AMP + D-ribose 5-phosphate
-
-
-
?
ADP-glucose + H2O
AMP + alpha-D-glucose 1-phosphate
-
at 21% of the activity with ADPribose
-
-
?
ADP-glucose + H2O
AMP + alpha-D-glucose 1-phosphate
56% of the activity with ADP-ribose
-
-
?
ADP-glucose + H2O
AMP + alpha-D-glucose 1-phosphate
about 70% of the activity with ADP-mannose
-
-
?
ADP-mannose + H2O
AMP + D-mannose 1-phosphate
-
-
-
?
ADP-mannose + H2O
AMP + D-mannose 1-phosphate
-
at 70% of the activity with ADPribose
-
-
?
ADP-mannose + H2O
AMP + D-mannose 1-phosphate
103% of the activity with ADP-ribose
-
-
?
ADP-ribose + H2O
AMP + D-ribose 5-phosphate
-
-
-
-
?
ADP-ribose + H2O
AMP + D-ribose 5-phosphate
-
-
-
?
ADP-ribose + H2O
AMP + D-ribose 5-phosphate
preferred substrate
-
-
?
ADP-ribose + H2O
AMP + D-ribose 5-phosphate
-
the enzyme may have a predominant role in free ADP-ribose turnover and as a protective agent preventing the accumulation of this potential dangerous metabolite
-
-
?
ADP-ribose + H2O
AMP + D-ribose 5-phosphate
-
protective enzyme whose function is to limit the intracellular accumulation of ADP-ribose
-
-
?
ADP-ribose + H2O
AMP + D-ribose 5-phosphate
the enzyme plays important roles in controlling the intracellular levels of ADPR and preventing non-enzymatic ADP-ribosylation of proteins by hydrolyzing ADPR to AMP and ribose 5?-phosphate
-
-
?
ADP-ribose + H2O
AMP + ribose 5-phosphate
-
-
-
?
ADP-ribose + H2O
AMP + ribose 5-phosphate
the function of the enzyme might be to remove free ADP-ribose arising from NAD+ and protein-bound poly- and non-enzymic protein glycation
-
-
?
ADP-ribose + H2O
AMP + ribose 5-phosphate
about 65% of the activity with ADP-mannose
-
-
?
ADP-ribose + H2O
AMP + ribose 5-phosphate
ADP-ribose is a better substrate compared with 8-oxo-dGDP
-
-
?
ADPribose + H2O
AMP + D-ribose 5-phosphate
-
-
-
?
ADPribose + H2O
AMP + D-ribose 5-phosphate
-
-
-
-
?
ADPribose + H2O
AMP + D-ribose 5-phosphate
-
-
-
?
ADPribose + H2O
AMP + D-ribose 5-phosphate
-
the enzyme may play an important role in the regulation of intracellular steady-state of free ADPribose
-
-
?
GDP-glucose + H2O
GMP + glucose 5-phosphate
7% of the activity with ADP-ribose
-
-
?
GDP-glucose + H2O
GMP + glucose 5-phosphate
about 15% of the activity with ADP-mannose
-
-
?
GDP-mannose + H2O
GMP + D-mannose 1-phosphate
-
at 40% of the activity with ADPribose
-
-
?
GDP-mannose + H2O
GMP + D-mannose 1-phosphate
about 15% of the activity with ADP-mannose
-
-
?
IDP-ribose + H2O
IMP + ribose 5-phosphate
-
at 59% of the activity with ADPribose
-
-
?
IDP-ribose + H2O
IMP + ribose 5-phosphate
9% of the activity with ADP-ribose
-
-
?
NADH + H2O
AMP + NMNH
7% of the activity with ADP-ribose
-
-
?
NADH + H2O
AMP + NMNH
about 12% of the activity with ADP-mannose
-
-
?
UDP-glucose + H2O
UMP + glucose 5-phosphate
-
at 5% of the activity with ADPribose
-
-
?
UDP-glucose + H2O
UMP + glucose 5-phosphate
about 12% of the activity with ADP-mannose
-
-
?
UDP-mannose + H2O
UMP + D-mannose 1-phosphate
-
at 20% of the activity with ADPribose
-
-
?
UDP-mannose + H2O
UMP + D-mannose 1-phosphate
about 15% of the activity with ADP-mannose
-
-
?
additional information
?
-
-
no activity with ADPglucose, ADPmannose, UDPglucose
-
-
?
additional information
?
-
-
hNUDT5 can utilize a variety of ADP-sugar conjugates as substrate, with a preference for ADPR
-
-
?
additional information
?
-
hNUDT5 can utilize a variety of ADP-sugar conjugates as substrate, with a preference for ADPR
-
-
?
additional information
?
-
ADP-ribose/CDP-alcohol diphosphatase (ADPRibase-Mn) acts as cyclic ADP-ribose (cADPR) phosphohydrolase with much lower efficiency than on its major substrates
-
-
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Breast Neoplasms
Author Correction: Targeted NUDT5 inhibitors block hormone signaling in breast cancer cells.
Breast Neoplasms
Expression of Oncogenic Drivers in 3D Cell Culture Depends on Nuclear ATP Synthesis by NUDT5.
Breast Neoplasms
Identification of NUDT5 Inhibitors From Approved Drugs.
Breast Neoplasms
Molecular docking based virtual screening of the breast cancer target NUDT5.
Breast Neoplasms
NUDT5 as a novel drug target and prognostic biomarker for ER-positive breast cancer.
Breast Neoplasms
Role of the NUDT Enzymes in Breast Cancer.
Breast Neoplasms
Targeted NUDT5 inhibitors block hormone signaling in breast cancer cells.
Breast Neoplasms
The high expression of NUDT5 indicates poor prognosis of breast cancer by modulating AKT / Cyclin D signaling.
Carcinogenesis
The high expression of MTH1 and NUDT5 promotes tumor metastasis and indicates a poor prognosis in patients with non-small-cell lung cancer.
Carcinoma
The high expression of MTH1 and NUDT5 predict a poor survival and are associated with malignancy of esophageal squamous cell carcinoma.
Colorectal Neoplasms
MutT-related proteins are novel progression and prognostic markers for colorectal cancer.
Cysts
Specific ADP-ribose pyrophosphatase from Artemia cysts and rat liver: effects of nitroprusside, fluoride and ionic strength.
Diabetes Mellitus, Type 2
No evidence of diabetes-specific CD38 (ADP ribosil cyclase/cyclic ADP-ribose hydrolase) autoantibodies by liquid-phase immunoprecipitation.
Endometrial Neoplasms
Differential expression of NUDT9 at different phases of the menstrual cycle and in different components of normal and neoplastic human endometrium.
Esophageal Squamous Cell Carcinoma
The high expression of MTH1 and NUDT5 predict a poor survival and are associated with malignancy of esophageal squamous cell carcinoma.
Infections
AtNUDT7, a negative regulator of basal immunity in Arabidopsis, modulates two distinct defense response pathways and is involved in maintaining redox homeostasis.
Lung Neoplasms
The high expression of MTH1 and NUDT5 promotes tumor metastasis and indicates a poor prognosis in patients with non-small-cell lung cancer.
Lymphatic Metastasis
MutT-related proteins are novel progression and prognostic markers for colorectal cancer.
Neoplasm Metastasis
Expression of Oncogenic Drivers in 3D Cell Culture Depends on Nuclear ATP Synthesis by NUDT5.
Neoplasm Metastasis
MutT-related proteins are novel progression and prognostic markers for colorectal cancer.
Neoplasm Metastasis
The high expression of MTH1 and NUDT5 promotes tumor metastasis and indicates a poor prognosis in patients with non-small-cell lung cancer.
Neoplasms
Expression of Oncogenic Drivers in 3D Cell Culture Depends on Nuclear ATP Synthesis by NUDT5.
Neoplasms
NUDT expression is predictive of prognosis in patients with clear cell renal cell carcinoma.
Neoplasms
NUDT5 as a novel drug target and prognostic biomarker for ER-positive breast cancer.
Neoplasms
Role of the NUDT Enzymes in Breast Cancer.
Neoplasms
The high expression of MTH1 and NUDT5 predict a poor survival and are associated with malignancy of esophageal squamous cell carcinoma.
Neoplasms
The high expression of MTH1 and NUDT5 promotes tumor metastasis and indicates a poor prognosis in patients with non-small-cell lung cancer.
Neoplasms
The high expression of NUDT5 indicates poor prognosis of breast cancer by modulating AKT / Cyclin D signaling.
Tuberculosis
High precision multi-genome scale reannotation of enzyme function by EFICAz.
Tuberculosis
Mycobacterium tuberculosis MutT1 (Rv2985) and ADPRase (Rv1700) constitute a two-stage mechanism of 8-oxo-dGTP and 8-oxo-GTP detoxification, and A to C mutation avoidance.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
0.0035 - 0.0038
8-oxo-dGDP
0.0209 - 0.3213
ADP-D-ribose
0.083
ADP-mannose
pH 7.0, 37°C
additional information
additional information
-
1.05
2',3'-cAMP
mutant N110A, pH 7.5, 37°C
1.25
2',3'-cAMP
mutant H111A, pH 7.5, 37°C
1.8
2',3'-cAMP
mutant H111N, pH 7.5, 37°C
2.3
2',3'-cAMP
mutant Q27H, pH 7.5, 37°C
2.4
2',3'-cAMP
wild-type, pH 7.5, 37°C
2.5
2',3'-cAMP
mutant F37Y, pH 7.5, 37°C
2.6
2',3'-cAMP
mutant C253A, pH 7.5, 37°C
3.4
2',3'-cAMP
mutant L196A, pH 7.5, 37°C
4.8
2',3'-cAMP
mutant F37A/L196A, pH 7.5, 37°C
5.1
2',3'-cAMP
mutant F37A, pH 7.5, 37°C
5.2
2',3'-cAMP
mutant F37A/L196F/C253A, pH 7.5, 37°C
7.1
2',3'-cAMP
mutant F37A/L196F, pH 7.5, 37°C
7.6
2',3'-cAMP
mutant F210A, pH 7.5, 37°C
7.6
2',3'-cAMP
mutant R43A, pH 7.5, 37°C
0.0035
8-oxo-dGDP
at pH 10.0 and 37°C
0.0038
8-oxo-dGDP
at pH 8.0 and 37°C
0.0209
ADP-D-ribose
mutant enzyme D164N, at pH 7.0 and 37°C
0.0223
ADP-D-ribose
wild type enzyme, at pH 7.0 and 37°C
0.0231
ADP-D-ribose
mutant enzyme E166Q, at pH 7.0 and 37°C
0.0257
ADP-D-ribose
mutant enzyme E116Q, at pH 7.0 and 37°C
0.0279
ADP-D-ribose
mutant enzyme R111Q, at pH 7.0 and 37°C
0.0389
ADP-D-ribose
mutant enzyme E93Q, at pH 7.0 and 37°C
0.0402
ADP-D-ribose
mutant enzyme E115Q, at pH 7.0 and 37°C
0.0434
ADP-D-ribose
mutant enzyme D164A, at pH 7.0 and 37°C
0.0456
ADP-D-ribose
mutant enzyme D133N, at pH 7.0 and 37°C
0.0463
ADP-D-ribose
mutant enzyme C139A, at pH 7.0 and 37°C
0.0702
ADP-D-ribose
mutant enzyme E112Q, at pH 7.0 and 37°C
0.0879
ADP-D-ribose
mutant enzyme D133A, at pH 7.0 and 37°C
0.1084
ADP-D-ribose
mutant enzyme R84Q, at pH 7.0 and 37°C
0.1197
ADP-D-ribose
mutant enzyme R196Q, at pH 7.0 and 37°C
0.1265
ADP-D-ribose
mutant enzyme W46A, at pH 7.0 and 37°C
0.1271
ADP-D-ribose
mutant enzyme Q82A, at pH 7.0 and 37°C
0.1283
ADP-D-ribose
mutant enzyme L98A, at pH 7.0 and 37°C
0.1497
ADP-D-ribose
mutant enzyme W28A/W46A, at pH 7.0 and 37°C
0.184
ADP-D-ribose
mutant enzyme W28A, at pH 7.0 and 37°C
0.3213
ADP-D-ribose
mutant enzyme R51Q, at pH 7.0 and 37°C
0.0019
ADP-ribose
at pH 8.0 and 37°C
0.0223
ADP-ribose
pH 7.0, 37°C, wild-type enzyme
0.032
ADP-ribose
pH 7.0, 37°C
0.036
ADP-ribose
at pH 10.0 and 37°C
0.06
ADP-ribose
pH 7.5, 37°C
0.06
ADP-ribose
wild-type, pH 7.5, 37°C
0.077
ADP-ribose
mutant F37Y, pH 7.5, 37°C
0.078
ADP-ribose
mutant H111N, pH 7.5, 37°C
0.094
ADP-ribose
mutant C253A, pH 7.5, 37°C
0.115
ADP-ribose
mutant R43A, pH 7.5, 37°C
0.13
ADP-ribose
mutant L196A, pH 7.5, 37°C
0.14
ADP-ribose
mutant H111A, pH 7.5, 37°C
0.2
ADP-ribose
mutant Q27H, pH 7.5, 37°C
0.29
ADP-ribose
mutant N110A, pH 7.5, 37°C
1.15
ADP-ribose
mutant F37A, pH 7.5, 37°C
1.15
ADP-ribose
mutant F37A/L196A, pH 7.5, 37°C
1.2
ADP-ribose
mutant F37A/L196F/C253A, pH 7.5, 37°C
1.6
ADP-ribose
mutant F37A/L196F, pH 7.5, 37°C
2.1
ADP-ribose
mutant F210A, pH 7.5, 37°C
0.0004
ADPribose
-
pH 7.5, 37°C
0.2
cADP-ribose
mutant C253A, pH 7.5, 37°C
0.46
cADP-ribose
mutant F37A/L196F/C253A, pH 7.5, 37°C
0.78
cADP-ribose
wild-type, pH 7.5, 37°C
0.35
CDP-choline
wild-type, pH 7.5, 37°C
0.43
CDP-choline
mutant F37Y, pH 7.5, 37°C
0.47
CDP-choline
mutant L196A, pH 7.5, 37°C
0.5
CDP-choline
mutant C253A, pH 7.5, 37°C
0.97
CDP-choline
mutant F37A, pH 7.5, 37°C
1.25
CDP-choline
mutant F37A/L196A, pH 7.5, 37°C
1.5
CDP-choline
mutant F37A/L196F, pH 7.5, 37°C
1.7
CDP-choline
mutant F37A/L196F/C253A, pH 7.5, 37°C
2.7
CDP-choline
mutant H111N, pH 7.5, 37°C
2.7
CDP-choline
mutant Q27H, pH 7.5, 37°C
4
CDP-choline
mutant N110A, pH 7.5, 37°C
7.5
CDP-choline
mutant H111A, pH 7.5, 37°C
9
CDP-choline
mutant R43A, pH 7.5, 37°C
11
CDP-choline
mutant F210A, pH 7.5, 37°C
additional information
additional information
-
kinetic analysis, Trp28 and Trp46 function synergistically in substrate binding and catalysis, overview
-
additional information
additional information
kinetic analysis, Trp28 and Trp46 function synergistically in substrate binding and catalysis, overview
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
0.0019 - 13.7
ADP-D-ribose
0.11
2',3'-cAMP
mutant N110A, pH 7.5, 37°C
0.95
2',3'-cAMP
mutant R43A, pH 7.5, 37°C
2 - 8
2',3'-cAMP
mutant F37A/L196F, pH 7.5, 37°C
2.7
2',3'-cAMP
mutant F210A, pH 7.5, 37°C
3 - 6
2',3'-cAMP
mutant F37A, pH 7.5, 37°C
4.3
2',3'-cAMP
mutant Q27H, pH 7.5, 37°C
7.4
2',3'-cAMP
mutant H111A, pH 7.5, 37°C
19
2',3'-cAMP
mutant F37A/L196A, pH 7.5, 37°C
20
2',3'-cAMP
mutant F37A/L196F/C253A, pH 7.5, 37°C
30
2',3'-cAMP
mutant L196A, pH 7.5, 37°C
34
2',3'-cAMP
mutant H111N, pH 7.5, 37°C
60
2',3'-cAMP
wild-type, pH 7.5, 37°C
70
2',3'-cAMP
mutant F37Y, pH 7.5, 37°C
83
2',3'-cAMP
mutant C253A, pH 7.5, 37°C
0.0019
ADP-D-ribose
mutant enzyme E112Q, at pH 7.0 and 37°C
0.0069
ADP-D-ribose
mutant enzyme E116Q, at pH 7.0 and 37°C
0.058
ADP-D-ribose
mutant enzyme W28A/W46A, at pH 7.0 and 37°C
0.1
ADP-D-ribose
mutant enzyme E166Q, at pH 7.0 and 37°C
0.18
ADP-D-ribose
mutant enzyme R84Q, at pH 7.0 and 37°C
0.32
ADP-D-ribose
mutant enzyme R111Q, at pH 7.0 and 37°C
0.41
ADP-D-ribose
mutant enzyme R51Q, at pH 7.0 and 37°C
2.7
ADP-D-ribose
mutant enzyme E115Q, at pH 7.0 and 37°C
4.5
ADP-D-ribose
mutant enzyme E93Q, at pH 7.0 and 37°C
6
ADP-D-ribose
mutant enzyme R196Q, at pH 7.0 and 37°C
7.3
ADP-D-ribose
mutant enzyme D133A, at pH 7.0 and 37°C
10.3
ADP-D-ribose
mutant enzyme Q82A, at pH 7.0 and 37°C
10.4
ADP-D-ribose
mutant enzyme D133N, at pH 7.0 and 37°C
11.3
ADP-D-ribose
mutant enzyme W46A, at pH 7.0 and 37°C
11.8
ADP-D-ribose
wild type enzyme, at pH 7.0 and 37°C
12.2
ADP-D-ribose
mutant enzyme D164A, at pH 7.0 and 37°C
12.4
ADP-D-ribose
mutant enzyme L98A, at pH 7.0 and 37°C
13.1
ADP-D-ribose
mutant enzyme D164N, at pH 7.0 and 37°C
13.3
ADP-D-ribose
mutant enzyme W28A, at pH 7.0 and 37°C
13.7
ADP-D-ribose
mutant enzyme C139A, at pH 7.0 and 37°C
0.003
ADP-ribose
mutant R43A, pH 7.5, 37°C
0.47
ADP-ribose
mutant H111A, pH 7.5, 37°C
2.3
ADP-ribose
mutant H111N, pH 7.5, 37°C
4.3
ADP-ribose
mutant N110A, pH 7.5, 37°C
5.5
ADP-ribose
pH 7.5, 37°C
7
ADP-ribose
mutant F37A/L196A, pH 7.5, 37°C
8
ADP-ribose
mutant F37A/L196F, pH 7.5, 37°C
10
ADP-ribose
mutant Q27H, pH 7.5, 37°C
11.4
ADP-ribose
pH 7.0, 37°C, wild-type enzyme
13
ADP-ribose
mutant F37A/L196F/C253A, pH 7.5, 37°C
14
ADP-ribose
mutant F37A, pH 7.5, 37°C
16
ADP-ribose
mutant L196A, pH 7.5, 37°C
19
ADP-ribose
mutant F210A, pH 7.5, 37°C
35
ADP-ribose
wild-type, pH 7.5, 37°C
50
ADP-ribose
mutant F37Y, pH 7.5, 37°C
97
ADP-ribose
mutant C253A, pH 7.5, 37°C
3.2
cADP-ribose
wild-type, pH 7.5, 37°C
8.9
cADP-ribose
mutant C253A, pH 7.5, 37°C
16
cADP-ribose
mutant F37A/L196F/C253A, pH 7.5, 37°C
0.025
CDP-choline
mutant R43A, pH 7.5, 37°C
2.2
CDP-choline
mutant H111A, pH 7.5, 37°C
5.3
CDP-choline
mutant H111N, pH 7.5, 37°C
5.7
CDP-choline
mutant N110A, pH 7.5, 37°C
25
CDP-choline
mutant F37A/L196A, pH 7.5, 37°C
26
CDP-choline
mutant F37A/L196F, pH 7.5, 37°C
29
CDP-choline
mutant L196A, pH 7.5, 37°C
33
CDP-choline
mutant F37A, pH 7.5, 37°C
37
CDP-choline
mutant F37A/L196F/C253A, pH 7.5, 37°C
39
CDP-choline
mutant Q27H, pH 7.5, 37°C
50
CDP-choline
wild-type, pH 7.5, 37°C
50
CDP-choline
mutant F210A, pH 7.5, 37°C
76
CDP-choline
mutant F37Y, pH 7.5, 37°C
79
CDP-choline
mutant C253A, pH 7.5, 37°C
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
0.0027 - 630
ADP-D-ribose
0.1
2',3'-cAMP
mutant N110A, pH 7.5, 37°C
0.13
2',3'-cAMP
mutant R43A, pH 7.5, 37°C
0.4
2',3'-cAMP
mutant F210A, pH 7.5, 37°C
1.9
2',3'-cAMP
mutant Q27H, pH 7.5, 37°C
3.9
2',3'-cAMP
mutant F37A/L196F, pH 7.5, 37°C
4
2',3'-cAMP
mutant F37A/L196A, pH 7.5, 37°C
4
2',3'-cAMP
mutant F37A/L196F/C253A, pH 7.5, 37°C
6
2',3'-cAMP
mutant H111A, pH 7.5, 37°C
7
2',3'-cAMP
mutant F37A, pH 7.5, 37°C
9
2',3'-cAMP
mutant L196A, pH 7.5, 37°C
19
2',3'-cAMP
mutant H111N, pH 7.5, 37°C
25
2',3'-cAMP
wild-type, pH 7.5, 37°C
28
2',3'-cAMP
mutant F37Y, pH 7.5, 37°C
32
2',3'-cAMP
mutant C253A, pH 7.5, 37°C
0.0027
ADP-D-ribose
mutant enzyme E112Q, at pH 7.0 and 37°C
0.005
ADP-D-ribose
mutant enzyme W28A/W46A, at pH 7.0 and 37°C
0.23
ADP-D-ribose
mutant enzyme E116Q, at pH 7.0 and 37°C
1.2
ADP-D-ribose
mutant enzyme R51Q, at pH 7.0 and 37°C
1.7
ADP-D-ribose
mutant enzyme R84Q, at pH 7.0 and 37°C
4.3
ADP-D-ribose
mutant enzyme E166Q, at pH 7.0 and 37°C
13
ADP-D-ribose
mutant enzyme R111Q, at pH 7.0 and 37°C
50
ADP-D-ribose
mutant enzyme R196Q, at pH 7.0 and 37°C
67
ADP-D-ribose
mutant enzyme E115Q, at pH 7.0 and 37°C
72
ADP-D-ribose
mutant enzyme W28A, at pH 7.0 and 37°C
81
ADP-D-ribose
mutant enzyme Q82A, at pH 7.0 and 37°C
83
ADP-D-ribose
mutant enzyme D133A, at pH 7.0 and 37°C
89
ADP-D-ribose
mutant enzyme W46A, at pH 7.0 and 37°C
97
ADP-D-ribose
mutant enzyme L98A, at pH 7.0 and 37°C
120
ADP-D-ribose
mutant enzyme E93Q, at pH 7.0 and 37°C
230
ADP-D-ribose
mutant enzyme D133N, at pH 7.0 and 37°C
300
ADP-D-ribose
mutant enzyme C139A, at pH 7.0 and 37°C
390
ADP-D-ribose
mutant enzyme D164A, at pH 7.0 and 37°C
530
ADP-D-ribose
wild type enzyme, at pH 7.0 and 37°C
630
ADP-D-ribose
mutant enzyme D164N, at pH 7.0 and 37°C
0.03
ADP-ribose
mutant R43A, pH 7.5, 37°C
3
ADP-ribose
mutant H111A, pH 7.5, 37°C
4.8
ADP-ribose
mutant F37A/L196F, pH 7.5, 37°C
6
ADP-ribose
mutant F37A/L196A, pH 7.5, 37°C
9
ADP-ribose
mutant F210A, pH 7.5, 37°C
11
ADP-ribose
mutant F37A/L196F/C253A, pH 7.5, 37°C
12
ADP-ribose
mutant F37A, pH 7.5, 37°C
15
ADP-ribose
mutant N110A, pH 7.5, 37°C
29
ADP-ribose
mutant H111N, pH 7.5, 37°C
52
ADP-ribose
mutant Q27H, pH 7.5, 37°C
120
ADP-ribose
mutant L196A, pH 7.5, 37°C
590
ADP-ribose
wild-type, pH 7.5, 37°C
650
ADP-ribose
mutant F37Y, pH 7.5, 37°C
1000
ADP-ribose
mutant C253A, pH 7.5, 37°C
0.0001
cADP-ribose
mutant R43A, pH 7.5, 37°C
0.008
cADP-ribose
mutant F210A, pH 7.5, 37°C
0.07
cADP-ribose
mutant H111A, pH 7.5, 37°C
0.13
cADP-ribose
mutant N110A, pH 7.5, 37°C
0.15
cADP-ribose
mutant Q27H, pH 7.5, 37°C
0.29
cADP-ribose
mutant H111N, pH 7.5, 37°C
0.9
cADP-ribose
mutant F37A/L196A, pH 7.5, 37°C
0.9
cADP-ribose
mutant L196A, pH 7.5, 37°C
1.3
cADP-ribose
mutant F37A, pH 7.5, 37°C
1.6
cADP-ribose
mutant F37A/L196F, pH 7.5, 37°C
4
cADP-ribose
wild-type, pH 7.5, 37°C
4.1
cADP-ribose
mutant F37Y, pH 7.5, 37°C
35.5
cADP-ribose
mutant F37A/L196F/C253A, pH 7.5, 37°C
44
cADP-ribose
mutant C253A, pH 7.5, 37°C
0.006
CDP-choline
mutant R43A, pH 7.5, 37°C
0.3
CDP-choline
mutant H111A, pH 7.5, 37°C
1.5
CDP-choline
mutant N110A, pH 7.5, 37°C
2
CDP-choline
mutant H111N, pH 7.5, 37°C
4
CDP-choline
mutant F210A, pH 7.5, 37°C
14
CDP-choline
mutant Q27H, pH 7.5, 37°C
17
CDP-choline
mutant F37A/L196F, pH 7.5, 37°C
21
CDP-choline
mutant F37A/L196A, pH 7.5, 37°C
22
CDP-choline
mutant F37A/L196F/C253A, pH 7.5, 37°C
34
CDP-choline
mutant F37A, pH 7.5, 37°C
62
CDP-choline
mutant L196A, pH 7.5, 37°C
150
CDP-choline
wild-type, pH 7.5, 37°C
160
CDP-choline
mutant C253A, pH 7.5, 37°C
180
CDP-choline
mutant F37Y, pH 7.5, 37°C
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
complexed with 8-oxo-dGMP, 8-oxo-dGDP and 8-oxo-dADP, hanging drop vapor diffusion method, using 0.8 M NaH2PO4/1.2M K2HPO4 and 0.1 M acetate (pH 4.5), and 0.2M ammonium acetate, 35-40% (w/v) polyethylene glycol 3350 and 0.1 M sodium citrate (pH 6.2)
in apo form, in complex with ADP-D-ribose, and in complex with AMP with bound Mg2+, hanging drop vapor diffusion method, using 160 mM sodium acetate (pH 5.5), and 25% (w/v) 2-methyl-2,4-pentanediol, or 300 mM di-ammonium hydrogen citrate, 6% (w/v) n-propanol and 15% (w/v) polyethylene glycol 3350, or 200 mM sodium acetate, 100 mM Tris-HCl (pH 8.0) and 30% (w/v) polyethylene glycol 4000
in complex with alpha,beta-methyleneadenosine diphosphoribose and 3 Mg2+ ions, hanging drop vapor diffusion method, using 250 mM sodium acetate, 100 mM Tris-HCl, pH 8.0, and 29% (w/v) polyethylene glycol 4000
purified recombinant wild-type and truncated mutant NUDT5 in complex with a non-hydrolyzable ADPR analogue, alpha,beta-methyleneadenosine diphosphoribose, and three Mg2+ ions representing the transition state of the enzyme during catalysis, 20 mg/ml protein is incubated with 5 mM AMPCPR and 10 mM MgCl2 at 4 °C overnight, followed by hanging drop vapour diffusion method, wild-type enzyme in complex with AMPCPR, and truncation mutant DELTAhNUDT5 in complex with AMPCPR and Mg2+, 4 °C, mixing of equal volumes of the protein solution and the reservoir solution containing 250 mM NaAc, 100 mM Tris-HCl, pH 8.0, and 29% PEG 4000, ingle crystals of the plate-shape morphology grow after 1 month, X-ray diffraction structure determination and anaylsis at 2.0 A resolution, molecular modelling
substrate docking on a homology model suggests possible interactions of ADP-ribose with seven residues located, with one exception (Cys253), either within the metallo-dependent phosphatases signature (Gln27, Asn110, His111), or in unique structural regions of the ADPRibase-Mn family: s2s3 (Phe37 and Arg43) and h7h8 (Phe210), around the active site entrance. Residue Phe37 is needed for ADP-ribose preference without catalytic effect. Arg43 is essential for catalysis. Cys253 is hindering for cADPR phosphohydrolase
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
C253A
mutant displays a tenfold increased efficiency for cADP-ribose, with no or modest effect on the other substrates
D164A
the mutant shows reduced catalytic efficiency compared to the wild type enzyme
D164N
the mutant shows increased catalytic efficiency compared to the wild type enzyme
E112Q
the mutant shows strongly reduced catalytic efficiency compared to the wild type enzyme
E115Q
the mutant shows reduced catalytic efficiency compared to the wild type enzyme
E116Q
the mutant shows reduced catalytic efficiency compared to the wild type enzyme
E166Q
the mutant shows reduced catalytic efficiency compared to the wild type enzyme
F210A
lowers 40-70fold the catalytic efficiency for ADP-ribose, CDP-choline and 2',3'-cAMP hydrolysis, and 500fold for cADP-ribose
F37A
19fold increased Km for ADP-ribose, with only a 2-3fold increase of the CDP-choline and 2',3'-cAMP Km values
F37A/L196A
mutation lessens the relative preference for ADP-ribose versus cADP-ribose
F37A/L196F
mutation lessens the relative preference for ADP-ribose versus cADP-ribose
F37A/L196F/C253G
site-directed mutagenesis, the mutant with a smaller residue 253 shows increased cADPR specificity
F37A/L196F/D250A/C253G
site-directed mutagenesis, the quadruple mutant shows a detrimental effect of the D250A substitution on the efficiency with all substrates (1.3-3.4fold decrease), and more markedly so for cADPR, such that the substrate efficiency ratios are less favourable than for the triple mutant F37A/L196F/C253G
F37A/L196F/V252A/C253G
site-directed mutagenesis, the mutant with displays the desired specificity, with cADPR kcat/KM is about 20-200fold larger than for any other substrate. The quadruple mutant shows detrimental effects of the V252A substitution on the efficiency with ADP-ribose, CDP-choline and 2',3'-cAMP (1.1-2.8fold decrease) while it increases 2fold the efficiency with cADPR
F37A/L196F/V252A/C253G/T279A
site-directed mutagenesis
F37Y
similar kinetic parameters as the wild type
H111A
marked efficiency decrease with all substrates except 2',3'-cAMP
H111N
marked efficiency decrease with all substrates except 2',3'-cAMP
L196A
mutation causes only a modest 2-5fold decrease of catalytic efficiency with the four substrates tested
N110A
100-250fold reduction in catalytic efficiency for the hydrolysis of CDP-choline or 2',3'-cAMP
Q27H
mutation reduces 11-13-fold the catalytic efficiency of the hydrolysis of ADP-ribose, CDP-choline or 2',3'-cAMP, and 27fold the hydrolysis of cADP-ribose
Q82A
the mutant shows reduced catalytic efficiency compared to the wild type enzyme
R111Q
the mutant shows reduced catalytic efficiency compared to the wild type enzyme
R43A
drastic decrease of catalytic efficiency
R84Q
the mutant shows reduced catalytic efficiency compared to the wild type enzyme
C139A
site-directed mutagenesis, mutation causes a 2.1fold increase in Km for ADP-ribose but has no effect on kcat compared to the wild-type enzyme
C139A
the mutant shows reduced catalytic efficiency compared to the wild type enzyme
D133A
site-directed mutagenesis, mutation causes a 4.0fold increase in Km for ADP-ribose but has no effect on kcat compared to the wild-type enzyme
D133A
the mutant shows reduced catalytic efficiency compared to the wild type enzyme
D133N
site-directed mutagenesis, mutation causes a 2.1fold increase in Km for ADP-ribose but has no effect on kcat compared to the wild-type enzyme
D133N
the mutant shows reduced catalytic efficiency compared to the wild type enzyme
E93Q
site-directed mutagenesis, mutation causes a 1.8fold increase in Km for ADP-ribose but has no effect on kcat compared to the wild-type enzyme
E93Q
the mutant shows reduced catalytic efficiency compared to the wild type enzyme
F37A/L196F/C253A
cyclic ADP-ribose is the best substrate for the mutant
F37A/L196F/C253A
site-directed mutagenesis, specific cyclic ADP-ribose phosphohydrolase obtained by mutagenic engineering of Mn2+-dependent ADP-ribose/CDP-alcohol diphosphatase. Mutagenesis of human ADPRibase-Mn at Phe37, Leu196 and Cys253 alters its specificity, the best substrate of the mutant is cyclic ADP-ribose (cADPR), the Cys253 mutation is essential for cADPR preference. The proximity to the northern ribose of cADPR in docking models indicates Cys253 is a steric constraint for cADPR positioning
L98A
site-directed mutagenesis, mutation of Leu98 to Ala causes a 5.8fold increase in Km but has no effect on kcat compared to the wild-type enzyme
L98A
the mutant shows reduced catalytic efficiency compared to the wild type enzyme
R196Q
site-directed mutagenesis, mutation causes a 5.5fold increase in Km for ADP-ribose but has no effect on kcat compared to the wild-type enzyme
R196Q
the mutant shows reduced catalytic efficiency compared to the wild type enzyme
R51Q
site-directed mutagenesis, the mutant shows a 14.6fold increased Km and a 17fold decreased kcat for ADP-ribose compared to the wild-type enzyme
R51Q
the mutant shows reduced catalytic efficiency compared to the wild type enzyme
W28A
site-directed mutagenesis, the mutant shows 8.4fold increased Km for ADP-ribose, but unaltered kcat compared to the wild-type enzyme
W28A
the mutant shows reduced catalytic efficiency compared to the wild type enzyme
W28A/W46A
site-directed mutagenesis, the mutant shows 53.7fold increased Km and a 219fold decreased kcat for ADP-ribose compared to the wild-type enzyme
W28A/W46A
the mutant shows strongly reduced catalytic efficiency compared to the wild type enzyme
W46A
site-directed mutagenesis, the mutant shows 5.7fold increased Km for ADP-ribose, but unaltered kcat compared to the wild-type enzyme
W46A
the mutant shows reduced catalytic efficiency compared to the wild type enzyme
additional information
-
construction of a truncation mutant DELTAhNUDT5
additional information
construction of a truncation mutant DELTAhNUDT5
additional information
design of mutations at or near residue 253 of human ADPRibase-Mn, in the vicinity of the adenine N1-linked (northern) ribose of cADPR, for altering the substrate specificity of the enzyme, overview
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Kim, Y.P.; Kahng, J.B.; Choi, J.Y.
Adenosine diphosphate ribose pyrophosphohydrolase in human skin
J. Dermatol.
7
11-15
1980
Homo sapiens
brenda
Kim, J.S.; Kim, W.Y.; Rho, H.W.; Park, J.W.; Park, B.H.; Han, M.K.; Kim, U.H.; Kim, H.R.
Purification and characterization of adenosine diphosphate ribose pyrophosphatase from human erythrocytes
Int. J. Biochem. Cell Biol.
30
629-638
1998
Homo sapiens
brenda
Gasmi, L.; Cartwright, J.L.; McLennan, A.G.
Cloning, expression and characterization of YSA1H, a human adenosine 5'-diphosphosugar pyrophosphatase possessing a MutT motif
Biochem. J.
344
331-337
1999
Homo sapiens (Q9UKK9), Homo sapiens
brenda
Ribeiro, J.M.; Carloto, A.; Costas, M.J.; Cameselle, J.C.
Human placenta hydrolases active on free ADP-ribose: an ADP-sugar pyrophosphatase and a specific ADP-ribose pyrophosphatase
Biochim. Biophys. Acta
1526
86-94
2001
Homo sapiens
brenda
Lin, S.; Gasmi, L.; Xie, Y.; Ying, K.; Gu, S.; Wang, Z.; Jin, H.; Chao, Y.; Wu, C.; Zhou, Z.; Tang, R.; Mao, Y.; McLennan, A.G.
Cloning, expression and characterisation of a human Nudix hydrolase specific for adenosine 5'-diphosphoribose (ADP-ribose)
Biochim. Biophys. Acta
1594
127-135
2001
Homo sapiens (Q9BW91), Homo sapiens
brenda
Yang, H.; Slupska, M.M.; Wei, Y.F.; Tai, J.H.; Luther, W.M.; Xia, Y.R.; Shih, D.M.; Chiang, J.H.; Baikkalov, C.; Fitz-Gibbon, S.; Phan, I.T.; Conrad, A.; Miller, J.H.
Cloning and characterization of a new member of nudix hydrolases from human and mouse
J. Biol. Chem.
275
8844-8853
2000
Homo sapiens (Q9UKK9), Homo sapiens, Mus musculus
brenda
Perraud, A.L.; Shen, B.; Dunn, C.A.; Rippe, K.; Smith, M.K.; Bessman, M.J.; Stoddard, B.L.; Scharenberg, A.M.
NUDT9, a member of the Nudix hydrolase family, is an evolutionarily conserved mitochondrial ADP-ribose pyrophosphatase
J. Biol. Chem.
278
1794-1801
2003
Homo sapiens
brenda
Carloto, A.; Costas, M.J.; Cameselle, J.C.; McLennan, A.G.; Ribeiro, J.M.
The specific, submicromolar-K(m) ADP-ribose pyrophosphatase purified from human placenta is enzymically indistinguishable from recombinant NUDT9 protein, including a selectivity for Mn(2+) as activating cation and increase in K(m) for ADP-ribose, both eli
Biochim. Biophys. Acta
1760
1545-1551
2006
Homo sapiens
brenda
Yu, H.N.; Song, E.K.; Yoo, S.M.; Lee, Y.R.; Han, M.K.; Yim, C.Y.; Kwak, J.Y.; Kim, J.S.
Activation of NUDT5, an ADP-ribose pyrophosphatase, by nitric oxide-mediated ADP-ribosylation
Biochem. Biophys. Res. Commun.
354
764-768
2007
Homo sapiens
brenda
Zha, M.; Guo, Q.; Zhang, Y.; Yu, B.; Ou, Y.; Zhong, C.; Ding, J.
Molecular mechanism of ADP-ribose hydrolysis by human NUDT5 from structural and kinetic studies
J. Mol. Biol.
379
568-578
2008
Homo sapiens, Homo sapiens (Q9UKK9)
brenda
Ito, R.; Sekiguchi, M.; Setoyama, D.; Nakatsu, Y.; Yamagata, Y.; Hayakawa, H.
Cleavage of oxidized guanine nucleotide and ADP sugar by human NUDT5 protein
J. Biochem.
149
731-738
2011
Homo sapiens (Q9UKK9), Homo sapiens
brenda
Zha, M.; Zhong, C.; Peng, Y.; Hu, H.; Ding, J.
Crystal structures of human NUDT5 reveal insights into the structural basis of the substrate specificity
J. Mol. Biol.
364
1021-1033
2006
Homo sapiens (Q9UKK9), Homo sapiens
brenda
Cabezas, A.; Ribeiro, J.; Rodrigues, J.; Lopez-Villamizar, I.; Fernandez, A.; Canales, J.; Pinto, R.; Costas, M.; Cameselle, J.
Molecular bases of catalysis and ADP-ribose preference of human Mn2+-dependent adpribose/CDP-alcohol diphosphatase and conversion by mutagenesis to a preferential cyclic ADP-ribose phosphohydrolase
PLoS ONE
10
e0118680
2015
Homo sapiens (W0NWJ0), Homo sapiens
brenda
Arimori, T.; Tamaoki, H.; Nakamura, T.; Kamiya, H.; Ikemizu, S.; Takagi, Y.; Ishibashi, T.; Harashima, H.; Sekiguchi, M.; Yamagata, Y.
Diverse substrate recognition and hydrolysis mechanisms of human NUDT5
Nucleic Acids Res.
39
8972-8983
2011
Homo sapiens (Q9UKK9), Homo sapiens
brenda
Furuike, Y.; Akita, Y.; Miyahara, I.; Kamiya, N.
ADP-ribose pyrophosphatase reaction in crystalline state conducted by consecutive binding of two manganese (II) ions as cofactors
Biochemistry
55
1801-1812
2016
Escherichia coli (Q93K97), Homo sapiens (Q9UKK9), Mycobacterium tuberculosis (O33199), Mycobacterium tuberculosis CDC 1551 (O33199), Mycobacterium tuberculosis Oshkosh (O33199), Thermus thermophilus, Thermus thermophilus (Q84CU3)
brenda
Ribeiro, J.M.; Canales, J.; Cabezas, A.; Rodrigues, J.R.; Pinto, R.M.; Lopez-Villamizar, I.; Costas, M.J.; Cameselle, J.C.
Specific cyclic ADP-ribose phosphohydrolase obtained by mutagenic engineering of Mn2+-dependent ADP-ribose/CDP-alcohol diphosphatase
Sci. Rep.
8
1036
2018
Homo sapiens (Q3LIE5)
brenda